164 related articles for article (PubMed ID: 11217818)
21. Olanzapine-induced hyperventilation: case report.
Sattar SP; Gastfriend DR
J Psychiatry Neurosci; 2002 Sep; 27(5):360-3. PubMed ID: 12271791
[TBL] [Abstract][Full Text] [Related]
22. Fungal dermatitis with olanzapine in schizophrenia.
Fogl T; Margolese HC
Can J Psychiatry; 2003 Oct; 48(9):643-4. PubMed ID: 14631890
[No Abstract] [Full Text] [Related]
23. Hypersensitivity syndrome due to trichloroethylene exposure: a severe generalized skin reaction resembling drug-induced hypersensitivity syndrome.
Watanabe H
J Dermatol; 2011 Mar; 38(3):229-35. PubMed ID: 21342224
[TBL] [Abstract][Full Text] [Related]
24. [Hypersensitivity syndrome caused by phenytoins and phenobarbital].
Fonseca JC; Azulay DR; Rozembau I; Azulay RD
Med Cutan Ibero Lat Am; 1984; 12(3):187-92. PubMed ID: 6237236
[TBL] [Abstract][Full Text] [Related]
25. Fever, delirium, autonomic instability, and monocytosis associated with olanzapine.
Robinson RL; Burk MS; Raman S
J Postgrad Med; 2003; 49(1):96. PubMed ID: 12865583
[No Abstract] [Full Text] [Related]
26. Aggression, agitation, and mania with olanzapine.
John V; Rapp M; Pies R
Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577
[No Abstract] [Full Text] [Related]
27. Ziprasidone alternative for olanzapine-induced hyperglycemia.
Spivak B; Alamy SS; Jarskog LF; Sheitman BB; Lieberman JA
Am J Psychiatry; 2002 Sep; 159(9):1606. PubMed ID: 12202289
[No Abstract] [Full Text] [Related]
28. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
Tas S; Simonart T
Acta Clin Belg; 1999 Aug; 54(4):197-200. PubMed ID: 10544509
[TBL] [Abstract][Full Text] [Related]
29. Dress syndrome and fulminant hepatic failure induced by lamotrigine.
Amante MF; Filippini AV; Cejas N; Lendoire J; Imventarza O; Parisi C
Ann Hepatol; 2009; 8(1):75-7. PubMed ID: 19221540
[TBL] [Abstract][Full Text] [Related]
30. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
Petkov T; Pehlivanov G; Grozdev I; Kavaklieva S; Tsankov N
Eur J Dermatol; 2007; 17(5):422-7. PubMed ID: 17673387
[TBL] [Abstract][Full Text] [Related]
31. Penicillin V-induced drug rash with eosinophilia and systemic symptoms.
Orbak Z; Sepetcigil O; Karakelleoğlu C; Gülses S
West Indian Med J; 2010 Dec; 59(6):722-5. PubMed ID: 21702250
[TBL] [Abstract][Full Text] [Related]
32. Liver toxicity due to olanzapine.
Domínguez-Jiménez JL; Puente-Gutiérrez JJ; Pelado-García EM; Cuesta-Cubillas D; García-Moreno AM
Rev Esp Enferm Dig; 2012 Dec; 104(11):617-8. PubMed ID: 23368661
[No Abstract] [Full Text] [Related]
33. Olanzapine-induced ketoacidosis with diabetes mellitus.
Lindenmayer JP; Patel R
Am J Psychiatry; 1999 Sep; 156(9):1471. PubMed ID: 10484968
[No Abstract] [Full Text] [Related]
34. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
Gordon JS; Neyman KM; Wells RD; Chen SC
Cutis; 2012 Apr; 89(4):180-2. PubMed ID: 22611746
[No Abstract] [Full Text] [Related]
35. Idiosyncratic reactions to phenytoin.
Powers NG; Carson SH
Clin Pediatr (Phila); 1987 Mar; 26(3):120-4. PubMed ID: 2949905
[TBL] [Abstract][Full Text] [Related]
36. [Drug-induced hypersensitivity syndrome--a literature review and the case report].
Gomułka K; Kuliczkowska D; Cisło M; Woźniak Z; Panaszek B
Pneumonol Alergol Pol; 2011; 79(1):52-6. PubMed ID: 21190154
[TBL] [Abstract][Full Text] [Related]
37. Diabetic ketoacidosis associated with olanzapine in an adolescent patient.
Selva KA; Scott SM
J Pediatr; 2001 Jun; 138(6):936-8. PubMed ID: 11391346
[TBL] [Abstract][Full Text] [Related]
38. Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
Leroux JL; Ghezail M; Chertok P; Blotman F
Clin Exp Rheumatol; 1992; 10(4):427. PubMed ID: 1356682
[No Abstract] [Full Text] [Related]
39. Severe akathisia during olanzapine treatment of acute schizophrenia.
Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
[TBL] [Abstract][Full Text] [Related]
40. Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapine.
Markowitz JS; DeVane CL; Boulton DW; Liston HL; Risch SC
J Clin Pharmacol; 2002 Jan; 42(1):104-6. PubMed ID: 11808820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
